Search Results

Displaying Results 5851-5875 of 7548 "'RARE'"

Jan 08, 2026, 06:48 ET DAVE STEWART FORMS RARE ENTITY TO CREATE BREAKTHROUGH IP AND BUILD VENTURES THAT MOVE CULTURE INTO NEW TERRITORY

creative businesses."What we do at RARE is unique. We combine creativity and operations to bring the most culturally relevant concepts in the world to life," said Rich Britton, Co-Founder of Rare."We're building a home for truly RARE ideas - ventures with heart, scale, and the

More news about: Rare Entity


Jan 08, 2026, 06:15 ET Energy Fuels Announces Updated Feasibility Study for Toliara Rare Earth and HMS Project in Madagascar Confirming World-Class Scale and Economics, Including $1.8 Billion NPV and Ramping Up to Over $500 Million of Expected Annual EBITDA

of titanium, zircon, and rare earth minerals.DENVER, Jan. 8, 2026 /PRNewswire/ - Energy Fuels Inc. (NYSE: UUUU) (TSX: EFR) (Energy Fuels or the Company), a leading U.S. producer of uranium, rare earth elements (REEs),

More news about: Energy Fuels Inc.


Jan 08, 2026, 05:30 ET Nobel Laureate Roger Penrose and Leading Thinkers Convene at Oxford to Examine the Nature of Reality, Consciousness, and God

time when artificial intelligence, cosmology, and neuroscience are reshaping humanity's self-understanding, the Nature of Reality Seminar offers a rare, high-level forum for examining whether science alone can account for existence—or whether it gestures toward realities beyond itself.EVENT

More news about: Palomar Editions


Jan 08, 2026, 04:01 ET Foresee Pharmaceuticals announces Global Licensing Agreement for MMP-12 Inhibitors with Primevera Therapeutics LLC

II clinical trial in asthma, with submission to the U.S. FDA expected in early 2026.FP-025: Preparing for future Phase II clinical trials in rare disease indications."Over the past decade Foresee has shown unwavering commitment to the discovery and development of MMP-12 inhibitors, which

More news about: Foresee Pharmaceuticals Co., Ltd.


Jan 08, 2026, 03:59 ET China's AGI Pioneer and Leader Z.ai Listed on Hong Kong Stock Exchange

civilization."Alex Zhou, Managing Partner of Qiming Venture Partners, said, "The Z.ai team combines deep conviction in its technical roadmap with a rare ability to consistently translate frontier research into real commercial value. This dual strength—a strong belief in technology coupled with disciplined

More news about: Qiming Venture Partners


Jan 08, 2026, 03:42 ET Foresee Pharmaceuticals announces Global Licensing Agreement for MMP-12 Inhibitors with Primevera Therapeutics LLC

II clinical trial in asthma, with submission to the U.S. FDA expected in early 2026.FP-025: Preparing for future Phase II clinical trials in rare disease indications."Over the past decade Foresee has shown unwavering commitment to the discovery and development of MMP-12 inhibitors, which

More news about: Foresee Pharmaceuticals Co., Ltd.


Jan 08, 2026, 03:41 ET China's AGI Pioneer and Leader Z.ai Listed on Hong Kong Stock Exchange

civilization."Alex Zhou, Managing Partner of Qiming Venture Partners, said, "The Z.ai team combines deep conviction in its technical roadmap with a rare ability to consistently translate frontier research into real commercial value. This dual strength—a strong belief in technology coupled with disciplined

More news about: Qiming Venture Partners


Jan 08, 2026, 03:00 ET TECregen Raises CHF 10 Million in Seed Financing and Appoints Dr. Bo Rode Hansen as Chairman

toward the clinic. The ability to modulate and restore thymic function paves the way for new therapeutic opportunities across immunology, oncology, and rare diseases. We are enthusiastic to support TECregen as it advances toward clinical development," remarked Dr. Philipp Müller, Investment Manager

More news about: TECregen AG


Jan 08, 2026, 00:58 ET The/Nudge Institute Appoints Devadas Krishnan as Chief Development Officer

livelihoods, building a strong, principled development function becomes critical," said Atul Satija, Founder & CEO, The/Nudge Institute. "Devadas brings a rare combination of operating rigour, leadership experience and a founder's mindset. His ability to build partnerships and institutions for long-term growth

More news about: The/Nudge Institute


Jan 07, 2026, 17:29 ET Aviation Safety Solutions Announces Addition of FAA SMS Workshop hosted by Aviation Performance Solutions in Mesa, AZ

https://courses.avsafetysolutions.com/p/faa-sms-workshop.This in-person workshop offers a rare opportunity to learn directly from three industry leaders in one setting and is an experience aviation safety professionals will not want to miss.About

More news about: Aviation Safety Solutions


Jan 07, 2026, 16:01 ET AMGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE

a broad and deep pipeline that builds on its existing portfolio of medicines to treat cancer, heart disease, osteoporosis, inflammatory diseases and rare diseases.In 2024, Amgen was named one of the "World's Most Innovative Companies" by Fast Company and one of "America's Best Large Employers"

More news about: Amgen


Jan 07, 2026, 14:29 ET Robert Stryk of Stryk Global Diplomacy Issues An Open Letter to President Donald J. Trump

President Trump:Your decisive actions in Venezuela demonstrate a rare clarity of purpose and a singular understanding of how true global capitalism advances human freedom and national sovereignty.Your leadership

More news about: Stryk Global Diplomacy


Jan 07, 2026, 14:10 ET American Society of Gene & Cell Therapy and Orphan Therapeutics Accelerator Partner to Advance and Commercialize Promising Rare Disease Treatments

clinical-stage therapies for ultra-rare conditions that have been shelved for financial or strategic reasons. OTXL utilizes alternative development and financing models to advance programs efficiently and sustainably, with proceeds reinvested to support additional rare disease therapies.For further

More news about: American Society of Gene & Cell Therapy and Orphan Therapeutics Accelerator


Jan 07, 2026, 13:24 ET Revenue Optics Appoints Ljupco Icevski as Executive Advisor in Strategic Move to Accelerate Commercial Development

distribution, manufacturing, and global supply chain environments. He has worked extensively with a wide cross-section of leadership teams globally, giving him rare, pattern-level insight into how commercial and go-to-market models perform across diverse end markets, ownership structures, and stages of maturity.

More news about: Revenue Optics


Jan 07, 2026, 13:21 ET Vision for Utah's Future Drives Historic Water Donation to the Great Salt Lake

generations to come."A conversation between Matt Garff and Utah State Representative Melissa G. Ballard helped catalyze the effort, identifying a rare opportunity to pair private infrastructure assets with public conservation goals at meaningful scale."This extraordinary donation exemplifies

More news about: MTNP


Jan 07, 2026, 13:02 ET Sobi to advance Gamifant® (emapalumab) in interferon-gamma-driven sepsis (IDS) based on EMBRACE topline data

in known or suspected Still's disease with an inadequate response or intolerance to glucocorticoids, or with recurrent MAS. Primary HLH is a rare syndrome of hyperinflammation that usually occurs within the first year of life and can rapidly become fatal unless diagnosed and treated. About

More news about: Swedish Orphan Biovitrum AB


Jan 07, 2026, 12:41 ET Sobi to advance Gamifant® (emapalumab) in interferon-gamma-driven sepsis (IDS) based on EMBRACE topline data

in known or suspected Still's disease with an inadequate response or intolerance to glucocorticoids, or with recurrent MAS. Primary HLH is a rare syndrome of hyperinflammation that usually occurs within the first year of life and can rapidly become fatal unless diagnosed and treated. About

More news about: Swedish Orphan Biovitrum AB


Jan 07, 2026, 11:00 ET Arbele Receives FDA Orphan Drug Designation for ARB1002, an Anti-CDH17 Antibody-Drug Conjugate for the Treatment of Pancreatic Cancer

therapies and poor long-term survival outcomes. The FDA's Orphan Drug Designation program is intended to incentivize the development of therapies for rare diseases affecting fewer than 200,000 patients in the United States, offering benefits that may include tax credits for qualified clinical development

More news about: Arbele


Jan 07, 2026, 10:57 ET GRAND CANYON UNIVERSITY EXTENDS TUITION FREEZE FOR 18th CONSECUTIVE YEAR

commitment to keeping a college education affordable to all socioeconomic classes and provides a level of predictability that has become increasingly rare in higher education.

More news about: Grand Canyon University


Jan 07, 2026, 10:45 ET RAAP: Alternative Funding Programs Put Rare Patients in Jeopardy

the Rare Access Action Project, is a coalition of life sciences and patient stakeholders that explore creative policy solutions to address structural issues in access and coverage. Our priority is to help ensure rare disease patients have access to the care

More news about: Rare Access Action Project (RAAP)


Jan 07, 2026, 10:45 ET Dr. Buzz Aldrin Selects Elon Musk to Receive the Dr. Buzz Aldrin Space Advancement Award at the 23rd Annual Living Legends of Aviation® Awards

most important recognition event in aviation, celebrating both historic achievements and breakthroughs shaping the next century of flight."It is rare that history gives us the chance to see two eras of space exploration celebrated together," said Stacey Elsner, Executive Director of the "Living Legends

More news about: Kiddie Hawk Air Academy


Jan 07, 2026, 10:10 ET Veterinarian's Doja Cat Trapped in Toxic Office

shamrock plant is very bitter, most pets avoid ingesting it," Dr. Schmid explained. "When it is ingested, it can cause a sudden drop in calcium, and in rare cases, acute renal failure."Dr. Muldoon provided Pet Poison Helpline with a list and description of the flowers and plants in the office and

More news about: Pet Poison Helpline


Jan 07, 2026, 10:00 ET USA-Made Wi-Fi HaLow Module: Advancing Long-Range, High-Throughput Connectivity While Reducing Costs for Edge AI and Industrial IoT

and it is clear that Gateworks was and remains the best choice for our requirements. Gateworks has exceeded our expectations across the board; it is rare to find a partner that delivers both top-tier technology and a genuine commitment to our success, but Gateworks does exactly that."Wi-Fi HaLow:

More news about: Morse Micro


Jan 07, 2026, 10:00 ET USA-Made Wi-Fi HaLow Module: Advancing Long-Range, High-Throughput Connectivity While Reducing Costs for Edge AI and Industrial IoT

and it is clear that Gateworks was and remains the best choice for our requirements. Gateworks has exceeded our expectations across the board; it is rare to find a partner that delivers both top-tier technology and a genuine commitment to our success, but Gateworks does exactly that."Wi-Fi HaLow:

More news about: Gateworks Corporation


Jan 07, 2026, 09:26 ET ExLabs to Deliver ChibaTech Payloads to Deep-Space as Part of Apophis Mission

Technology (ChibaTech) and its Planetary Exploration Research Center (PERC) to send university-led payloads to the surface of asteroid Apophis during its rare near-Earth flyby in 2029. ApophisExL is the world's first commercial deep-space rideshare and is supported by mission design and operations collaboration

More news about: ExLabs


Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.